Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea · Delayed Price · Currency is KRW 91,100
-600 (-0.65%)
Mar 27, 2026, 1:49 PM KST
KRX:185750 Revenue
In the year 2025, Chong Kun Dang Pharmaceutical had annual revenue of 1.69T KRW with 6.68% growth. Chong Kun Dang Pharmaceutical had revenue of 426.78B in the quarter ending December 31, 2025, with 2.75% growth.
Revenue
1.69T
Revenue Growth
+6.68%
P/S Ratio
0.71
Revenue / Employee
751.18M
Employees
2,253
Market Cap
1.21T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.69T | 105.97B | 6.68% |
| Dec 31, 2024 | 1.59T | -82.97B | -4.97% |
| Dec 31, 2023 | 1.67T | 181.06B | 12.17% |
| Dec 31, 2022 | 1.49T | 144.79B | 10.78% |
| Dec 31, 2021 | 1.34T | 40.55B | 3.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewoong | 2.07T |
| GC Biopharma | 1.99T |
| Daewoong Pharmaceutical | 1.57T |
| Dong-A Socio Holdings | 1.40T |
| Boryung | 1.02T |
| DongKook Pharmaceutical | 926.88B |
| Huons Global | 825.44B |
| JW Pharmaceutical | 775.30B |